Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × palbociclib × Other neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 124 Gastrointestinal 19 Sarcoma 12 Thoracic 10 Lymphoid 9 Head & Neck 9 Gynecologic 9 Genitourinary 9 CNS 8 Other hematologic neoplasm 7 Tumor-Agnostic 6 Dermatologic 5 Other solid neoplasm 4 Plasma cell 3 Classical hematology 2 Other neoplasm 1 Myeloid 1

Conditions

Breast Cancer Metastatic 1

Interventions

Surveys and Questionnaires 9 Cyclophosphamide 9 Whole-Body Irradiation 7 Biopsy 7 fludarabine phosphate 6 Peripheral Blood Stem Cell Transplantation 6 Educational Status 6 Early Intervention, Educational 6 Busulfan 6 Methotrexate 5 Methods 5 Immunohistochemistry 5 Epoetin Alfa 5 Tacrolimus 4 Mycophenolic Acid 4 Interviews as Topic 4 Gene Expression Profiling 4 Decitabine 4 Cyclosporine 4 Celecoxib 4 Antilymphocyte Serum 4 fludarabine 3 Sirolimus 3 Radiotherapy 3 Paclitaxel 3 Microarray Analysis 3 Melphalan 3 Magnetic Resonance Spectroscopy 3 Imiquimod 3 Fentanyl 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04483505 2023-12-28

ROGABREAST

Fundacion CRIS de Investigación para Vencer el Cáncer

Phase 1 Completed

BreastOther neoplasm

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡